Mayne Pharma Group (ASX: MYX) Share Price

MYX

$2.41▼-2.03%

$195.8MRank #664 on ASXHealthcareDrug Manufacturers - General

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$195.8M

Volume

89K

P/E Ratio

-4.23

EPS

-$0.1839

Dividend Yield

0.00%

52-Week High

$6.50

52-Week Low

$2.04

Beta

1.028

Mayne Pharma Group (ASX: MYX) is an Australian-listed company in the Healthcare sector with a market capitalisation of $195.8M and the 664th-largest security on the ASX by market capitalisation. The MYX share price is $2.41, down 2.03% today and down 52.28% over the past 12 months. Shares have traded between $2.04 and $6.50 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Mayne Pharma Group reported revenue of $212.1M and a net loss of $14.9M.

Charts

$2.41

24H Range

$2.39

$2.48

52-Week Range

$2.04

$6.50

About Mayne Pharma Group Limited

Mayne Pharma Group Ltd. operates as a specialized pharmaceutical enterprise, dedicated to the global production and distribution of both proprietary (branded) and unbranded (generic) medicinal products. Its extensive market reach spans Australia, New Zealand, North America (the United States and Canada), Europe, and Asia. The company's business activities are organized across four distinct divisions: Metrics Contract Services, International, Branded Products, and Portfolio Products. Mayne Pharma offers innovative oral drug delivery technologies and provides comprehensive contract services, including pharmaceutical development, manufacturing, and analytical support to external clients. Furthermore, the firm specializes in the distribution of pharmaceutical products tailored for key therapeutic areas such as dermatology, women's health, and infectious diseases. Incorporated in 2005, and headquartered in Salisbury South, Australia, the company was formerly known as Halcygen Pharmaceuticals Limited before rebranding to Mayne Pharma Group Limited in November 2010.

IPO Date

29 June 2007

CEO

Aaron Gray

Employees

850

Website

maynepharma.com

Key Financial Data

Revenue (Quarterly)	$212.1M
Net Income (Quarterly)	$-14.9M
Total Assets	$940.5M
Total Debt	$44.6M
Free Cash Flow	$-9.4M
Return on Equity	-4.24%
Profit Margin	-7.04%
Operating Margin	-13.28%

MYX Frequently Asked Questions

What is the Mayne Pharma Group (ASX: MYX) share price?

The MYX share price is $2.41, down 2.03% for the day, based on the latest available ASX market data.

What is Mayne Pharma Group's market capitalisation?

Mayne Pharma Group has a market capitalisation of $195.8M, making it the 664th-largest security listed on the ASX.

Does Mayne Pharma Group pay a dividend?

MYX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Mayne Pharma Group profitable?

In its most recent reported period (ending 31 Dec 2025), MYX reported revenue of $212.1M and a net loss of $14.9M.

How many MYX shares are on issue?

Mayne Pharma Group has approximately 81,245,827 shares on issue, based on its market capitalisation of $195.8M and current share price.

What sector is Mayne Pharma Group in?

Mayne Pharma Group is classified in the Healthcare sector, within the Drug Manufacturers - General industry on the ASX.

When did Mayne Pharma Group list on the ASX?

Mayne Pharma Group listed on the Australian Securities Exchange on 29 June 2007.

Latest News

What’s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares?

Kalkine5 June 2026

What’s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares? Kalkine

Insights: Mayne Pharma Group Ltd (ASX:MYX)

smallcaps.com.au30 Oct 2025

Insights: Mayne Pharma Group Ltd (ASX:MYX) smallcaps.com.au

How many employees work at Mayne Pharma Group?

Revelio Labs7 May 2026

How many employees work at Mayne Pharma Group? Revelio Labs

Mayne Pharma signals short-term pain as it resets for growth

The Motley Fool Australia22 Dec 2025

Mayne Pharma signals short-term pain as it resets for growth The Motley Fool Australia

Meet the forgetful, incurious PE dealmaker behind the Mayne debacle

AFR9 Nov 2025

Meet the forgetful, incurious PE dealmaker behind the Mayne debacle AFR

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
AYAArtrya Limited	$512.1M	$4.50	-13.78	0.00%	▼-4.26%
AVRAnteris Technologies Ltd	$482.7M	$13.12	-0.94	0.00%	▼-2.81%
IMRImricor Medical Systems, Inc.	$436.7M	$1.75	-6.61	0.00%	▲+4.17%
AFPAFT Pharmaceuticals Limited	$321.9M	$3.07	7.71	0.00%	▼-5.54%
MVFMonash IVF Group Limited	$266.9M	$0.685	10.00	0.00%	▲+2.24%
OCCOrthocell Limited	$163.2M	$0.735	-12.98	0.00%	▼-1.34%
DXBDimerix Limited	$99.1M	$0.165	-5.17	0.00%	▼-2.94%
IMMImmutep Limited	$69.3M	$0.047	-3.40	0.00%	–+0.00%

ETFs That Hold MYX

MYX is held by 3 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.06% of its portfolio.

Fund	Portfolio Weight	Fund Size
ISOiShares S&P/ASX Small Ordinaries ETF	0.06%	$134.5M
QOZBetaShares - FTSE RAFI Australia 200 ETF	0.01%	$1.21B
VASVanguard Australian Shares Index ETF	0.01%	$26.10B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.45	$2.48	$2.39	$2.41	85K	▼-2.43%
11 June 2026	$2.36	$2.49	$2.32	$2.47	321K	▲+2.07%
10 June 2026	$2.40	$2.45	$2.35	$2.42	261K	▲+0.83%
9 June 2026	$2.30	$2.41	$2.26	$2.40	274K	▲+4.35%
8 June 2026	$2.30	$2.36	$2.23	$2.30	151K	▼-1.71%
5 June 2026	$2.30	$2.36	$2.23	$2.34	146K	▲+5.41%
4 June 2026	$2.27	$2.27	$2.20	$2.22	164K	▼-2.20%
3 June 2026	$2.25	$2.315	$2.21	$2.27	209K	▲+0.89%
2 June 2026	$2.32	$2.32	$2.22	$2.25	326K	▼-3.43%
1 June 2026	$2.41	$2.41	$2.28	$2.33	360K	▼-2.92%
29 May 2026	$2.48	$2.50	$2.385	$2.40	120K	▼-4.00%
28 May 2026	$2.40	$2.61	$2.39	$2.50	376K	▲+3.31%
27 May 2026	$2.34	$2.45	$2.30	$2.42	210K	▲+3.42%
26 May 2026	$2.38	$2.39	$2.33	$2.34	66K	▼-2.70%
25 May 2026	$2.42	$2.51	$2.32	$2.405	249K	▼-1.43%
22 May 2026	$2.39	$2.55	$2.335	$2.44	367K	▲+3.39%
21 May 2026	$2.27	$2.37	$2.27	$2.36	173K	▲+2.83%
20 May 2026	$2.29	$2.32	$2.27	$2.295	206K	▲+0.22%
19 May 2026	$2.32	$2.36	$2.29	$2.29	91K	▼-1.29%
18 May 2026	$2.29	$2.33	$2.23	$2.32	293K	▲+0.87%
15 May 2026	$2.29	$2.34	$2.28	$2.30	246K	–+0.00%
14 May 2026	$2.37	$2.37	$2.29	$2.30	168K	▼-1.71%
13 May 2026	$2.39	$2.41	$2.33	$2.34	199K	▼-2.30%
12 May 2026	$2.51	$2.51	$2.36	$2.395	262K	▼-3.62%
11 May 2026	$2.59	$2.59	$2.44	$2.485	317K	▼-3.68%
8 May 2026	$2.58	$2.59	$2.55	$2.58	124K	▼-0.77%
7 May 2026	$2.65	$2.66	$2.59	$2.60	46K	–+0.00%
6 May 2026	$2.68	$2.69	$2.55	$2.60	265K	▼-2.26%
5 May 2026	$2.81	$2.81	$2.65	$2.66	159K	▼-5.00%
4 May 2026	$2.77	$2.84	$2.77	$2.80	116K	▲+0.54%

About Mayne Pharma Group Limited

IPO Date

29 June 2007

CEO

Aaron Gray

Employees

850

Website

maynepharma.com

MYX Frequently Asked Questions

What is the Mayne Pharma Group (ASX: MYX) share price?

The MYX share price is $2.41, down 2.03% for the day, based on the latest available ASX market data.

What is Mayne Pharma Group's market capitalisation?

Mayne Pharma Group has a market capitalisation of $195.8M, making it the 664th-largest security listed on the ASX.

Does Mayne Pharma Group pay a dividend?

MYX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Mayne Pharma Group profitable?

In its most recent reported period (ending 31 Dec 2025), MYX reported revenue of $212.1M and a net loss of $14.9M.

How many MYX shares are on issue?

Mayne Pharma Group has approximately 81,245,827 shares on issue, based on its market capitalisation of $195.8M and current share price.

What sector is Mayne Pharma Group in?

Mayne Pharma Group is classified in the Healthcare sector, within the Drug Manufacturers - General industry on the ASX.

When did Mayne Pharma Group list on the ASX?

Mayne Pharma Group listed on the Australian Securities Exchange on 29 June 2007.

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
AYAArtrya Limited	$512.1M	$4.50	-13.78	0.00%	▼-4.26%
AVRAnteris Technologies Ltd	$482.7M	$13.12	-0.94	0.00%	▼-2.81%
IMRImricor Medical Systems, Inc.	$436.7M	$1.75	-6.61	0.00%	▲+4.17%
AFPAFT Pharmaceuticals Limited	$321.9M	$3.07	7.71	0.00%	▼-5.54%
MVFMonash IVF Group Limited	$266.9M	$0.685	10.00	0.00%	▲+2.24%
OCCOrthocell Limited	$163.2M	$0.735	-12.98	0.00%	▼-1.34%
DXBDimerix Limited	$99.1M	$0.165	-5.17	0.00%	▼-2.94%
IMMImmutep Limited	$69.3M	$0.047	-3.40	0.00%	–+0.00%

ETFs That Hold MYX

MYX is held by 3 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.06% of its portfolio.

Fund

Portfolio Weight

Fund Size

ISOiShares S&P/ASX Small Ordinaries ETF

0.06%

$134.5M

QOZBetaShares - FTSE RAFI Australia 200 ETF

0.01%

$1.21B

VASVanguard Australian Shares Index ETF

0.01%

$26.10B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.45	$2.48	$2.39	$2.41	85K	▼-2.43%
11 June 2026	$2.36	$2.49	$2.32	$2.47	321K	▲+2.07%
10 June 2026	$2.40	$2.45	$2.35	$2.42	261K	▲+0.83%
9 June 2026	$2.30	$2.41	$2.26	$2.40	274K	▲+4.35%
8 June 2026	$2.30	$2.36	$2.23	$2.30	151K	▼-1.71%
5 June 2026	$2.30	$2.36	$2.23	$2.34	146K	▲+5.41%
4 June 2026	$2.27	$2.27	$2.20	$2.22	164K	▼-2.20%
3 June 2026	$2.25	$2.315	$2.21	$2.27	209K	▲+0.89%
2 June 2026	$2.32	$2.32	$2.22	$2.25	326K	▼-3.43%
1 June 2026	$2.41	$2.41	$2.28	$2.33	360K	▼-2.92%
29 May 2026	$2.48	$2.50	$2.385	$2.40	120K	▼-4.00%
28 May 2026	$2.40	$2.61	$2.39	$2.50	376K	▲+3.31%
27 May 2026	$2.34	$2.45	$2.30	$2.42	210K	▲+3.42%
26 May 2026	$2.38	$2.39	$2.33	$2.34	66K	▼-2.70%
25 May 2026	$2.42	$2.51	$2.32	$2.405	249K	▼-1.43%
22 May 2026	$2.39	$2.55	$2.335	$2.44	367K	▲+3.39%
21 May 2026	$2.27	$2.37	$2.27	$2.36	173K	▲+2.83%
20 May 2026	$2.29	$2.32	$2.27	$2.295	206K	▲+0.22%
19 May 2026	$2.32	$2.36	$2.29	$2.29	91K	▼-1.29%
18 May 2026	$2.29	$2.33	$2.23	$2.32	293K	▲+0.87%
15 May 2026	$2.29	$2.34	$2.28	$2.30	246K	–+0.00%
14 May 2026	$2.37	$2.37	$2.29	$2.30	168K	▼-1.71%
13 May 2026	$2.39	$2.41	$2.33	$2.34	199K	▼-2.30%
12 May 2026	$2.51	$2.51	$2.36	$2.395	262K	▼-3.62%
11 May 2026	$2.59	$2.59	$2.44	$2.485	317K	▼-3.68%
8 May 2026	$2.58	$2.59	$2.55	$2.58	124K	▼-0.77%
7 May 2026	$2.65	$2.66	$2.59	$2.60	46K	–+0.00%
6 May 2026	$2.68	$2.69	$2.55	$2.60	265K	▼-2.26%
5 May 2026	$2.81	$2.81	$2.65	$2.66	159K	▼-5.00%
4 May 2026	$2.77	$2.84	$2.77	$2.80	116K	▲+0.54%